Cite
HARVARD Citation
Alayed, Y. et al. (2019). MRI assisted focal boost integrated with HDR monotherapy study in low and intermediate risk prostate cancer (MARS): Results from a phase II clinical trial. Radiotherapy and oncology. pp. 144-148. [Online].